- Home
- GALT vs FSTR Comparison
GALT vs FSTR Comparison
Compare GALT & FSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | FSTR |
|---|---|---|
| Founded | 2000 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 397.3M | 442.3M |
| IPO Year | 2008 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GALT | FSTR |
|---|---|---|
| Price | $3.49 | $35.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 197.8K | 38.5K |
| Earning Date | 11-13-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | N/A | ★ $540,009,000.00 |
| Revenue This Year | N/A | $4.14 |
| Revenue Next Year | N/A | $2.54 |
| P/E Ratio | ★ N/A | $81.84 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $2.03 | $24.30 |
| 52 Week High | $7.13 | $45.81 |
Technical Indicators
Market Signals| Indicator | GALT | FSTR |
|---|---|---|
| Relative Strength Index (RSI) | 45.36 | 45.19 |
| Support Level | $2.71 | $34.03 |
| Resistance Level | $3.56 | $43.03 |
| Average True Range (ATR) | 0.23 | 0.77 |
| MACD | -0.02 | 0.14 |
| Stochastic Oscillator | 41.34 | 70.56 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About FSTR L.B. Foster Company
L.B. Foster Co is a technology solutions provider of products and services for the rail and infrastructure markets. The company has two reporting segments: Rail, Technologies, and Services (Rail); and Infrastructure Solutions (Infrastructure). Maximum revenue is generated from the Rail segment, which is comprised of several manufacturing and distribution businesses that provide products and services for freight and passenger railroads and industrial companies throughout the world. The Infrastructure segment offers engineered precast concrete solutions, as well as fabricated bridge, protective pipe coating, and pipe threading offerings across North America. Geographically, the company generates maximum revenue from the United States, followed by Canada, the UK, and other markets.